[go: up one dir, main page]

WO2000037100A3 - Compositions and methods for reducing or preventing fertilization in fish and birds - Google Patents

Compositions and methods for reducing or preventing fertilization in fish and birds Download PDF

Info

Publication number
WO2000037100A3
WO2000037100A3 PCT/CA1999/001225 CA9901225W WO0037100A3 WO 2000037100 A3 WO2000037100 A3 WO 2000037100A3 CA 9901225 W CA9901225 W CA 9901225W WO 0037100 A3 WO0037100 A3 WO 0037100A3
Authority
WO
WIPO (PCT)
Prior art keywords
reducing
fish
birds
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA1999/001225
Other languages
French (fr)
Other versions
WO2000037100A2 (en
Inventor
Robert Brown
Bill Pohajdak
Warwick Charles Kimmins
Janet Horrocks
Leslie Maclaren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalhousie University
Original Assignee
Dalhousie University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalhousie University filed Critical Dalhousie University
Priority to EP99960753A priority Critical patent/EP1140151A2/en
Priority to AU17653/00A priority patent/AU1765300A/en
Priority to CA002356452A priority patent/CA2356452A1/en
Priority to US09/868,983 priority patent/US6790457B1/en
Publication of WO2000037100A2 publication Critical patent/WO2000037100A2/en
Publication of WO2000037100A3 publication Critical patent/WO2000037100A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed is an immunocontraceptive vaccine composition comprising a teleost homolog of zona pellucida (TH-ZP), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a fish, and a method for its use. Also disclosed is an immunocontraceptive vaccine composition comprising an antigen from an inner perivitelline layer (IPVL), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a bird, and a method for its use.
PCT/CA1999/001225 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds Ceased WO2000037100A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99960753A EP1140151A2 (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds
AU17653/00A AU1765300A (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds
CA002356452A CA2356452A1 (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds
US09/868,983 US6790457B1 (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11352698P 1998-12-22 1998-12-22
US60/113,526 1998-12-22

Publications (2)

Publication Number Publication Date
WO2000037100A2 WO2000037100A2 (en) 2000-06-29
WO2000037100A3 true WO2000037100A3 (en) 2000-12-07

Family

ID=22349942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1999/001225 Ceased WO2000037100A2 (en) 1998-12-22 1999-12-22 Compositions and methods for reducing or preventing fertilization in fish and birds

Country Status (4)

Country Link
EP (1) EP1140151A2 (en)
AU (1) AU1765300A (en)
CA (1) CA2356452A1 (en)
WO (1) WO2000037100A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498493B2 (en) 2007-09-27 2016-11-22 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5909500A (en) * 1999-07-01 2001-01-22 University Of Georgia Research Foundation, Inc., The Method and composition for affecting reproductive systems
AU2002214861B2 (en) 2000-11-07 2006-09-28 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
WO2003101482A2 (en) * 2002-05-31 2003-12-11 Genesis Group Inc. Liposome vaccine formulations for fin-fish
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
CA2723918C (en) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
GB201204280D0 (en) 2012-03-09 2012-04-25 Univ Nordland Methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012247A1 (en) * 1991-01-09 1992-07-23 Proteus Molecular Design Limited Analogs of piscine lhrh
WO1993025231A1 (en) * 1992-06-05 1993-12-23 Dalhousie University Use of zona pellucida glycoproteins for immunocontraception
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1992012247A1 (en) * 1991-01-09 1992-07-23 Proteus Molecular Design Limited Analogs of piscine lhrh
WO1993025231A1 (en) * 1992-06-05 1993-12-23 Dalhousie University Use of zona pellucida glycoproteins for immunocontraception

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG Y.S. ET AL: "Molecular cloning, structural analysis and expression of carp ZP2 gene", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 46, 1997, pages 258 - 267, XP000891751 *
CHANG Y.S. ET AL: "Molecular cloning, structural analysis and expression of carp zp3 gene", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 44, 1996, pages 295 - 304, XP000891769 *
DATABASE SCISEARCH [online] MOCHIDA K ET AL: "SPERM INFERTILITY CAUSED BY EXPERIMENTAL TESTICULAR AUTOIMMUNITY IN THE NILE TILAPIA", XP002134944, retrieved from STN Database accession no. 159365 *
HINDS LYN A ET AL: "Immuno-contraceptive control for carp.", 1997, WORKSHOP;ALBURY, NEW SOUTH WALES, AUSTRALIA; OCTOBER 22-24, 1996, CONTROLLING CARP: EXPLORING THE OPTIONS FOR AUSTRALIA. 1997 CSIRO PUBLICATIONS 314 ALBERT STREET, EAST MELBOURNE, VICTORIA, AUSTRALIA, PAGE(S) 108-118, ISBN: 0-643-05883-4, XP000879881 *
HJERTEN S ET AL: "Studies of fish zona pellucida by high-performance ion-exchange chromatography on agarose columns and free zone electrophoresis", JOURNAL OF CHROMATOGRAPHY BIOMEDICAL APPLICATIONS, vol. 341, 1985, pages 295 - 304, XP000891408 *
NIPPON SUISAN GAKKAISHI-BULLETIN OF THE JAPANESE SOCIETY OF SCIENTIFIC FISHERIES, (FEB 1993) VOL. 59, NO. 2, PP. 253-261. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498493B2 (en) 2007-09-27 2016-11-22 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

Also Published As

Publication number Publication date
EP1140151A2 (en) 2001-10-10
AU1765300A (en) 2000-07-12
WO2000037100A2 (en) 2000-06-29
CA2356452A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
MY113488A (en) Compounds with growth hormone releasing properties
WO2000037100A3 (en) Compositions and methods for reducing or preventing fertilization in fish and birds
WO2001006950A3 (en) Aneurysm embolization material and device
DE69933169D1 (en) Single crystal gallium nitride substrate and process for its preparation
CA2455134A1 (en) Adjuvants for use in vaccines
AP9801384A0 (en) Improvements of implantation rates after in vitro fertilization.
EP0800765A3 (en) A method for preparing organs for long-term preservation and transplantation
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
WO2003039345A3 (en) Stent delivery device with embolic protection
WO2003077733A3 (en) Method and apparatus for accessing the left atrial appendage
AU7814498A (en) Multivalent (in ovo) avian vaccine
WO2004002562A3 (en) Introducer sheath
DE60034662D1 (en) TREATMENT OF BARRENESS
AU3842502A (en) Composition for regulating animal growth, method of manufacture and use thereof
ATE367087T1 (en) FORMULATIONS FOR TREATING DISEASES AND PROCEDURES USING THEM
ES2186280T3 (en) IMPLANT WITH A SILICONE NUCLEUS FOR A PROLONGED RELEASE OF ANDROGEN.
WO2000013650A3 (en) Neuroprotection
WO2002022523A3 (en) Methods and mixtures for treating distressed trees
WO2001008695A3 (en) Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility
AU2001220437A1 (en) Degradable crosslinkers, compositions therefrom, and methods of their preparation and use
AU3054900A (en) Stable activated novel carbamic acid derivatives, preparation method and use forpreparing urea
DE60237017D1 (en) BIOSICHERHEITSSYTEM
ATE384085T1 (en) RELEASE AGENT CONTAINING ALPHA OLEFIN MONOMER FOR PRODUCING VISCOSITY-REDUCING AGENTS AND METHOD FOR PRODUCING VISCOSITY-REDUCING AGENTS USING RELEASE AGENTS CONTAINING ALPHA OLEFIN MONOMER
DE69623652D1 (en) FORMULATION FOR PEPTIDE RELEASE
EP1209914A3 (en) Apparatus and method for creating distribution content

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2000 17653

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2356452

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2356452

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999960753

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999960753

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09868983

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999960753

Country of ref document: EP